128 related articles for article (PubMed ID: 37963445)
21. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation.
Bal JS; Thuluvath PJ
Liver Int; 2003 Aug; 23(4):243-8. PubMed ID: 12895263
[TBL] [Abstract][Full Text] [Related]
22. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
Kanda E; Yoshida M; Sasaki S
BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
[TBL] [Abstract][Full Text] [Related]
23. The role of fibroblast growth factor-23 in cardiorenal syndrome.
Kovesdy CP; Quarles LD
Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
[TBL] [Abstract][Full Text] [Related]
24. Prolonged QTc interval in children and young adults with sickle cell disease at steady state.
Liem RI; Young LT; Thompson AA
Pediatr Blood Cancer; 2009 Jul; 52(7):842-6. PubMed ID: 19229972
[TBL] [Abstract][Full Text] [Related]
25. Electrocardiographic measurements in children with pre-dialysis chronic kidney disease and undergoing kidney replacement therapy.
Leventoğlu E; Büyükkaragöz B; Kavas FÇ; Holoğlu MC; Kavgacı A; Fidan K; Dalgıç A; Bakkaloğlu SA; Tunaoğlu FS; Söylemezoğlu O
Eur J Pediatr; 2023 Nov; 182(11):4993-5005. PubMed ID: 37624446
[TBL] [Abstract][Full Text] [Related]
26. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience.
Ali T; Idrees MK; ; Akhtar SF
Saudi J Kidney Dis Transpl; 2017; 28(6):1375-1380. PubMed ID: 29265050
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
Akhabue E; Wong M; Mehta R; Isakova T; Wolf M; Yancy C; Gutierrez OM; Carnethon M
Am Heart J; 2022 Mar; 245():10-18. PubMed ID: 34861237
[TBL] [Abstract][Full Text] [Related]
29. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
Kim JY; Lee Y; Kang HG; Ha IS; Cheong HI; Choi HJ; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS; Cho H
BMC Nephrol; 2020 Dec; 21(1):533. PubMed ID: 33297989
[TBL] [Abstract][Full Text] [Related]
30. Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
Shi HT; Wang XJ; Li J; Song GF; Huang ZY; Guo XY; Guo JJ; Lv ZY; Li HW; Ge JB; Cui J; Qi GM
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26553212
[TBL] [Abstract][Full Text] [Related]
31. Inter-relationship between electrocardiographic left ventricular hypertrophy and QT prolongation as predictors of increased risk of mortality in the general population.
Soliman EZ; Shah AJ; Boerkircher A; Li Y; Rautaharju PM
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):400-6. PubMed ID: 24762807
[TBL] [Abstract][Full Text] [Related]
32. Serum albumin level and abnormal corrected QT interval in patients with coronary artery disease and chronic kidney disease.
Wu CC; Lu YC; Yu TH; Wang CP; Hung WC; Tang WH; Tsai IT; Chung FM; Lee YJ; Hu JJ
Intern Med J; 2018 Oct; 48(10):1242-1251. PubMed ID: 29573083
[TBL] [Abstract][Full Text] [Related]
33. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
[TBL] [Abstract][Full Text] [Related]
35. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
37. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
38. QTc prolongation prior to angiography predicts poor outcome and associates significantly with lower left ventricular ejection fractions and higher left ventricular end-diastolic pressures.
van der Bijl P; Heradien M; Doubell A; Brink P
Cardiovasc J Afr; 2012 Nov; 23(10):541-5. PubMed ID: 23192258
[TBL] [Abstract][Full Text] [Related]
39. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
Dounousi E; Mitsis M; Naka KK; Pappas C; Lakkas L; Harisis C; Pappas K; Koutlas V; Tzalavra I; Spanos G; Michalis LK; Siamopoulos KC
Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
